Black Rock Inc. Cue Biopharma, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 756,736 shares of CUE stock, worth $756,736. This represents 0.0% of its overall portfolio holdings.
Number of Shares
756,736
Previous 2,244,103
66.28%
Holding current value
$756,736
Previous $4.24 Million
77.88%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CUE
# of Institutions
52Shares Held
14.1MCall Options Held
14.4KPut Options Held
2.6K-
Bleichroeder LP New York, NY5MShares$5 Million1.28% of portfolio
-
Slate Path Capital LP New York, NY2.4MShares$2.4 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$2.03 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA509KShares$508,8270.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$478,5000.01% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $35.4M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...